BeiGene's Patent Research and Practical Operation Guide for Tislelizumab

In recent years, the rise of biologics is an established fact. Antibody drugs, such as Merck's PD-1 monoclonal antibody Keytruda, have become top-sellers. As a result, patent research on antibody drugs has gained importance. The goal is to compile comprehensive and accurate patent information to support infringement analysis, biosimilar development, investment, and R&D. High-quality patent research reports on antibody drugs now represent a core competitive advantage, playing a crucial role at various corporate stages. This research involves several coordinated steps: patent search, patent screening, clinical analysis, and concluding recommendations. The following sections will detail these steps.